Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in REGENERON PHARMACEUTICALS
BNP PARIBAS FINANCIAL MARKETS holds 448,371 shares of REGN (REGENERON PHARMACEUTICALS), worth $346.4M as of 2026-Q1. The position was increased (+1.7% shares). REGN represents 0.2% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$346.4M
Current Shares
448,371
Total Value Change
+$87.1M
Total Shares Change
+201,680
Other major holders of REGN: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 448,371 |
+1.7% |
| $346.4M |
| 0.2% |
| $766.66 |
38 |
| 2025-Q4 | Decreased | 440,844 | -7.7% | $340.3M | 0.2% | $773.94 | 0 |
| 2025-Q3 | Decreased | 477,652 | -8.9% | $268.6M | 0.1% | $560.05 | 0 |
| 2025-Q2 | Decreased | 524,358 | -29.8% | $275.3M | 0.2% | $519.56 | 0 |
| 2025-Q1 | Increased | 746,613 | +38.4% | $473.5M | 0.3% | $634.66 | 49 |
| 2024-Q4 | Increased | 539,596 | +82.7% | $384.4M | 0.2% | $698.71 | 57 |
| 2024-Q3 | Increased | 295,412 | +19.8% | $310.5M | 0.2% | $1,036.94 | 44 |
| 2024-Q2 | Increased | 246,691 | +2.9% | $259.3M | 0.2% | $1,045.23 | 38 |